{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T10:16:23Z","timestamp":1785838583141,"version":"3.56.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T00:00:00Z","timestamp":1757808000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"National Science Centre Poland","doi-asserted-by":"publisher","award":["2023\/48\/C\/NZ7\/00036"],"award-info":[{"award-number":["2023\/48\/C\/NZ7\/00036"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013920","name":"Uniwersytet im. Adama Mickiewicza w Poznaniu","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013920","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ejmech.2025.118159","type":"journal-article","created":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T16:41:58Z","timestamp":1757781718000},"page":"118159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Design, synthesis and in vitro assessment of di-\/tri-methoxy-aryl-substituted mono-spiro-1,2,4,5-tetraoxanes for antiplasmodial and anticancer use"],"prefix":"10.1016","volume":"300","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6946-1986","authenticated-orcid":false,"given":"Mohit K.","family":"Tiwari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Kucinska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Zgo\u0142a-Grze\u015bkowiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marziyeh","family":"Raeispour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Murias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Grellier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141ukasz","family":"Marczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Goslinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118159_bib1","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1158\/1541-7786.MCR-23-0411","article-title":"Updating the definition of cancer","volume":"21","author":"Brown","year":"2023","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.ejmech.2025.118159_bib2","unstructured":"Cancer-Key Facts, World Health Organ. WHO (n.d. ). https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cancer."},{"key":"10.1016\/j.ejmech.2025.118159_bib3","unstructured":"Types of Cancer Treatment - NCI, Natl. Cancer Inst. (n.d. ). https:\/\/www.cancer.gov\/about-cancer\/treatment\/types."},{"key":"10.1016\/j.ejmech.2025.118159_bib4","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nrclinonc.2013.158","article-title":"Drug rechallenge and treatment beyond Progression\u2014implications for drug resistance","volume":"10","author":"Kuczynski","year":"2013","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2025.118159_bib5","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1039\/D0FO03001E","article-title":"The role of natural products in the prevention and treatment of pulmonary fibrosis: a review","volume":"12","author":"Wang","year":"2021","journal-title":"Food Funct."},{"key":"10.1016\/j.ejmech.2025.118159_bib6","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/med.21979","article-title":"An overview on the antimalarial activity of 1,2,4\u2010trioxanes, 1,2,4\u2010trioxolanes and 1,2,4,5\u2010tetraoxanes","volume":"44","author":"Shukla","year":"2024","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2025.118159_bib7","doi-asserted-by":"crossref","first-page":"7360","DOI":"10.1021\/acs.jmedchem.5b01380","article-title":"Artemisinin-derived dimers: potent antimalarial and anticancer agents","volume":"59","author":"Fr\u00f6hlich","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118159_bib8","unstructured":"MMV's pipeline of antimalarial drugs, (n.d. ). https:\/\/www.mmv.org\/mmv-pipeline-antimalarial-drugs."},{"key":"10.1016\/j.ejmech.2025.118159_bib9","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1002\/med.21657","article-title":"Artemisinin\u2010derived antimalarial endoperoxides from bench\u2010side to bed\u2010side: chronological advancements and future challenges","volume":"40","author":"Tiwari","year":"2020","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2025.118159_bib10","first-page":"113","article-title":"Synthesis of nonsymmetrical 1,2,4,5-Tetraoxanes","author":"Amado","year":"2024","journal-title":"Past and Current Routes"},{"key":"10.1016\/j.ejmech.2025.118159_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2022\/1458143","article-title":"The potential mechanisms by which artemisinin and its derivatives induce ferroptosis in the treatment of cancer","volume":"2022","author":"Hu","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ejmech.2025.118159_bib12","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1002\/cmdc.201700804","article-title":"Novel peroxides as promising anticancer agents with unexpected depressed antimalarial activity","volume":"13","author":"Coghi","year":"2018","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2025.118159_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202200328","article-title":"Antimalarial and anticancer activity evaluation of bridged ozonides, aminoperoxides, and tetraoxanes","volume":"17","author":"Coghi","year":"2022","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2025.118159_bib14","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s00044-016-1736-2","article-title":"Cyclic peroxides as promising anticancer agents: in vitro cytotoxicity study of synthetic ozonides and tetraoxanes on human prostate cancer cell lines","volume":"26","author":"Yaremenko","year":"2017","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2025.118159_bib15","doi-asserted-by":"crossref","first-page":"5118","DOI":"10.1021\/jm070684m","article-title":"Deoxycholic acid-derived tetraoxane antimalarials and antiproliferatives","volume":"50","author":"Terzi\u0107","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118159_bib16","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.1002\/anie.201001026","article-title":"Identification of a 1,2,4,5\u2010Tetraoxane antimalarial drug\u2010development candidate (RKA 182) with superior properties to the semisynthetic artemisinins","volume":"49","author":"O'Neill","year":"2010","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2025.118159_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107893","article-title":"Searching for the holy grail \u2212 highly potent bridged endoperoxides for targeted cancer therapy","volume":"153","author":"Tiwari","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118159_bib18","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1055\/s-1988-27586","article-title":"Efficient preparation of 1,2,4,5-Tetroxanes from bis(trimethylsilyl) peroxide and carbonyl compounds","volume":"1988","author":"Jefford","year":"1988","journal-title":"Synthesis"},{"key":"10.1016\/j.ejmech.2025.118159_bib19","doi-asserted-by":"crossref","first-page":"6309","DOI":"10.1016\/S0040-4039(03)01472-2","article-title":"One-pot synthesis of non-symmetric tetraoxanes with the H2O2\/MTO\/fluorous alcohol system","volume":"44","author":"Iskra","year":"2003","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2025.118159_bib20","doi-asserted-by":"crossref","first-page":"4880","DOI":"10.1016\/j.tetlet.2012.07.001","article-title":"A facile and efficient Bi(III) catalyzed synthesis of 1,1-dihydroperoxides and 1,2,4,5-tetraoxanes","volume":"53","author":"Sashidhara","year":"2012","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2025.118159_bib21","doi-asserted-by":"crossref","first-page":"6118","DOI":"10.1016\/j.tet.2016.08.043","article-title":"Optimisation of the synthesis of second generation 1,2,4,5 tetraoxane antimalarials","volume":"72","author":"O\u2019 Neill","year":"2016","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2025.118159_bib22","doi-asserted-by":"crossref","first-page":"10608","DOI":"10.1021\/acs.joc.1c01258","article-title":"Synthesis of non-symmetrical Dispiro-1,2,4,5-Tetraoxanes and Dispiro-1,2,4-Trioxanes catalyzed by silica Sulfuric Acid","volume":"86","author":"Amado","year":"2021","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2025.118159_bib23","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.tet.2005.11.022","article-title":"Fluorinated alcohol directed formation of dispiro-1,2,4,5-tetraoxanes by hydrogen peroxide under acid conditions","volume":"62","author":"\u017dmitek","year":"2006","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2025.118159_bib24","doi-asserted-by":"crossref","first-page":"7790","DOI":"10.1016\/j.bmc.2006.07.069","article-title":"Synthesis and antimalarial activities of novel 3,3,6,6-tetraalkyl-1,2,4,5-tetraoxanes","volume":"14","author":"\u017dmitek","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118159_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114774","article-title":"N-sulfonylpiperidinedispiro-1,2,4,5-tetraoxanes exhibit potent in vitro antiplasmodial activity and in vivo efficacy in mice infected with P. berghei ANKA","volume":"244","author":"Singh","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118159_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.134572","article-title":"3\u2032,4\u2032,5\u2032-trimethoxy- and 3,4-dimethoxychalcones targeting A549 cells: synthesis, cytotoxic activity, and molecular docking","volume":"1275","author":"Danova","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.118159_bib27","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ejmech.2014.12.050","article-title":"Synthesis, anticancer activity and molecular docking studies on a series of heterocyclic trans-cyanocombretastatin analogues as antitubulin agents","volume":"92","author":"Penthala","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118159_bib28","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1021\/acs.jcim.0c01144","article-title":"Understanding ring puckering in small molecules and cyclic peptides","volume":"61","author":"Chan","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2025.118159_bib29","doi-asserted-by":"crossref","first-page":"10757","DOI":"10.1021\/acs.joc.7b01368","article-title":"Natural products and their mimics as targets of opportunity for discovery","volume":"82","author":"Martin","year":"2017","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2025.118159_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113685","article-title":"Novel halogenated arylvinyl-1,2,4 trioxanes as potent antiplasmodial as well as anticancer agents: synthesis, bioevaluation, structure-activity relationship and in-silico studies","volume":"224","author":"Tiwari","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118159_bib31","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1002\/cmdc.202000045","article-title":"Design, synthesis, structure\u2010activity relationship and docking studies of novel functionalized Arylvinyl\u20101,2,4\u2010Trioxanes as potent antiplasmodial as well as anticancer agents","volume":"15","author":"Tiwari","year":"2020","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2025.118159_bib32","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3390\/ph15030360","article-title":"Biological evaluation in resistant cancer cells and Study of mechanism of action of Arylvinyl-1,2,4-Trioxanes","volume":"15","author":"Ng","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2025.118159_bib33","doi-asserted-by":"crossref","first-page":"5982","DOI":"10.1128\/AAC.00709-12","article-title":"In Vitro activity of fluorescent dyes against asexual blood stages of Plasmodium falciparum","volume":"56","author":"Joanny","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2025.118159_bib34","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.bcp.2011.04.018","article-title":"Effects of highly active novel artemisinin\u2013chloroquinoline hybrid compounds on \u03b2-hematin formation, parasite morphology and endocytosis in Plasmodium falciparum","volume":"82","author":"Feng","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118159_bib35","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1021\/acsmedchemlett.5b00468","article-title":"Discovery of a selective series of inhibitors of Plasmodium falciparum HDACs","volume":"7","author":"Ontoria","year":"2016","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118159_bib36","doi-asserted-by":"crossref","first-page":"7392","DOI":"10.1016\/j.bmc.2013.09.047","article-title":"Synthesis and evaluation of the antimalarial, anticancer, and caspase 3 activities of tetraoxane dimers","volume":"21","author":"Amewu","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118159_bib37","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1021\/jm050966r","article-title":"Tetraoxane antimalarials and their reaction with Fe(II)","volume":"49","author":"Opsenica","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118159_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/chem.202301315","article-title":"Molecular and crystal structure, spectroscopy, and photochemistry of a dispiro compound bearing the tetraoxane pharmacophore","volume":"29","author":"Amado","year":"2023","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.ejmech.2025.118159_bib39","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s10637-008-9197-1","article-title":"Mixed steroidal tetraoxanes induce apoptotic cell death in tumor cells, invest","volume":"27","author":"\u017di\u017eak","year":"2009","journal-title":"N. Drugs"},{"key":"10.1016\/j.ejmech.2025.118159_bib40","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/1759-7714.12572","article-title":"Blocking transferrin receptor inhibits the growth of lung adenocarcinoma cells in vitro","volume":"9","author":"Wu","year":"2018","journal-title":"Thorac. Cancer"},{"key":"10.1016\/j.ejmech.2025.118159_bib41","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41419-024-06688-5","article-title":"Iron promotes ovarian cancer malignancy and advances platinum resistance by enhancing DNA repair via FTH1\/FTL\/POLQ\/RAD51 axis","volume":"15","author":"Zhang","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2025.118159_bib42","article-title":"Molecular mechanisms of cisplatin resistance in ovarian cancer","volume":"11","author":"Jiang","year":"2024","journal-title":"Genes Dis"},{"key":"10.1016\/j.ejmech.2025.118159_bib43","doi-asserted-by":"crossref","first-page":"12512","DOI":"10.1039\/D2DT02068H","article-title":"Comparative NMR metabolomics of the responses of A2780 human ovarian cancer cells to clinically established Pt-based drugs","volume":"51","author":"Ghini","year":"2022","journal-title":"Dalton Trans."},{"key":"10.1016\/j.ejmech.2025.118159_bib44","doi-asserted-by":"crossref","first-page":"17829","DOI":"10.1039\/D4DT01571A","article-title":"Multi-functional biotinylated platinum(iv)\u2013SAHA conjugate for tumor-targeted chemotherapy","volume":"53","author":"Gupta","year":"2024","journal-title":"Dalton Trans."},{"key":"10.1016\/j.ejmech.2025.118159_bib45","doi-asserted-by":"crossref","first-page":"18526","DOI":"10.3390\/molecules201018526","article-title":"Highly stable tetra-Phenolato Titanium(IV) agent formulated into nanoparticles demonstrates anti-tumoral activity and selectivity","volume":"20","author":"Meker","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.118159_bib46","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.3892\/mmr.2016.4897","article-title":"Oridonin effectively reverses cisplatin drug resistance in human ovarian cancer cells via induction of cell apoptosis and inhibition of matrix metalloproteinase expression","volume":"13","author":"Ma","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ejmech.2025.118159_bib47","doi-asserted-by":"crossref","first-page":"473","DOI":"10.4149\/neo_2010_05_473","article-title":"Synthetic isothiocyanate indole-3-ethyl isothiocyanate (homoITC) enhances sensitivity of human ovarian carcinoma cell lines A2780 and A2780\/CP to cisplatin","volume":"57","author":"Stehlik","year":"2010","journal-title":"Neoplasma"},{"key":"10.1016\/j.ejmech.2025.118159_bib48","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1179\/1973947815Y.0000000021","article-title":"Rapamycin enhanced the antitumor efficacy of oxaliplatin in cisplatin-resistant ovarian cancer cells A2780cis both in vitro and in vivo","volume":"27","author":"Liu","year":"2015","journal-title":"J. Chemother."},{"key":"10.1016\/j.ejmech.2025.118159_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241310581","article-title":"Investigation of anticancer properties of monoterpene-aminopyrimidine hybrids on A2780 ovarian cancer cells","volume":"24","author":"Nagy","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.118159_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.783317","article-title":"Cajanol sensitizes A2780\/Taxol cells to paclitaxel by inhibiting the PI3K\/Akt\/NF-\u03baB signaling pathway","volume":"12","author":"Sui","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118159_bib51","doi-asserted-by":"crossref","first-page":"60453","DOI":"10.18632\/oncotarget.19728","article-title":"Drug resistance reversal in ovarian cancer cells of paclitaxel and borneol combination therapy mediated by PEG-PAMAM nanoparticles","volume":"8","author":"Zou","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2025.118159_bib52","first-page":"1119","article-title":"Silibinin restores paclitaxel sensitivity to paclitaxel-resistant human ovarian carcinoma cells","volume":"28","author":"Zhou","year":"2008","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ejmech.2025.118159_bib53","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.biopha.2013.09.004","article-title":"Expression of MDR1 and MDR3 gene products in paclitaxel-, doxorubicin- and vincristine-resistant cell lines","volume":"68","author":"Januchowski","year":"2014","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2025.118159_bib54","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.118159_bib55","doi-asserted-by":"crossref","first-page":"W357","DOI":"10.1093\/nar\/gkz382","article-title":"SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules","volume":"47","author":"Daina","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2025.118159_bib56","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/trf.15734","article-title":"Inactivation of Plasmodium falciparum in whole blood using the amustaline and glutathione pathogen reduction technology","volume":"60","author":"Sow","year":"2020","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.ejmech.2025.118159_bib57","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2307\/3280287","article-title":"Synchronization of Plasmodium falciparum erythrocytic stages in culture","volume":"65","author":"Lambros","year":"1979","journal-title":"J. Parasitol."},{"key":"10.1016\/j.ejmech.2025.118159_bib58","doi-asserted-by":"crossref","first-page":"668","DOI":"10.4103\/pm.pm_100_17","article-title":"Brazilian cerrado Qualea grandiflora Mart. leaves exhibit antiplasmodial and trypanocidal activities in vitro","volume":"13","author":"Cordeiro","year":"2017","journal-title":"Pharmacogn. Mag."},{"key":"10.1016\/j.ejmech.2025.118159_bib59","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ejmech.2019.04.052","article-title":"Thiazolidinone\/thiazole based hybrids \u2013 new class of antitrypanosomal agents","volume":"174","author":"Kryshchyshyn","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118159_bib60","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1007\/s00044-024-03233-z","article-title":"Morpholinated curcuminoids against urinary bladder cancer cells: synthesis and anticancer evaluation","volume":"33","author":"Bakun","year":"2024","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2025.118159_bib61","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1021\/acs.jmedchem.5b00052","article-title":"Phthalocyanine derivatives possessing 2-(Morpholin-4-yl)ethoxy groups as potential agents for photodynamic therapy","volume":"58","author":"Kucinska","year":"2015","journal-title":"J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425009249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425009249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T05:58:13Z","timestamp":1773122293000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425009249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":61,"alternative-id":["S0223523425009249"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118159","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and in vitro assessment of di-\/tri-methoxy-aryl-substituted mono-spiro-1,2,4,5-tetraoxanes for antiplasmodial and anticancer use","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118159","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118159"}}